Showing results (2261-2270 of 2,307) with videos related to
Sort By:
Pageof 231
International Journal of Pediatric Otorhinolaryngology|May 2, 2016
International Pediatric Otolaryngology Group (IPOG) consensus recommendations: Routine peri-operative pediatric tracheotomy careJulie E Strychowsky, David Albert, Kenny Chan, et al.Science Advances|April 14, 2018
HEx: A heterologous expression platform for the discovery of fungal natural productsColin J B Harvey, Mancheng Tang, Ulrich Schlecht, et al.The Lancet Regional Health. Western Pacific|February 22, 2024
Overcoming silos in health care systems through meso-level organisations - a case study of health reforms in New South Wales, AustraliaDavid Peiris, Anne-Marie Feyer, Justine Barnard, et al.Journal of Attention Disorders|February 17, 2024
The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) ProjectSara Carucci, Alessandro Zuddas, Angelico Lampis, et al.Journal of Neurotrauma|July 9, 2020
In-Hospital Mortality for the Elderly with Acute Traumatic Spinal Cord InjuryTom Inglis, Dan Banaszek, Carly S Rivers, et al.Journal of Medicinal Chemistry|April 15, 2005
Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenzaSimon J F Macdonald, Rachel Cameron, Derek A Demaine, et al.Acta Neuropathologica|August 30, 2019
The dystroglycan receptor maintains glioma stem cells in the vascular nicheBryan W Day, Justin D Lathia, Zara C Bruce, et al.JAMA Neurology|May 26, 2018
Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive ImpairmentDavid A Wolk, Carl Sadowsky, Beth Safirstein, et al.Antimicrobial Agents and Chemotherapy|November 25, 2004
Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimenSimon J F Macdonald, Keith G Watson, Rachel Cameron, et al.Science (New York, N.Y.)|May 1, 2025
Bespoke plant glycoconjugates for gut microbiota-mediated drug targetingWei Jen Ma, Changqing Wang, Jagatheeswaran Kothandapani, et al.Pageof 231